Market Overview

UPDATE: Bank of America Upgrades Bruker Corporation to Neutral on Improving Fundamentals

Share:
Related BRKR
Deutsche Bank Optimistic On Fundamentals In Life Science Tools/Diagnostics Sector
Pressure Biosciences CEO On Its Beaten Down Stock: 'We Can Now Begin To Focus On The Area That Is Most Important'

Bank of America upgraded Bruker Corporation (NASDAQ: BRKR) from Underperform to Neutral and raised the price objective from $15.00 to $19.50.

Bank of America noted, "Although we've been positive on BRKR's technology and long-term outlook, we've been cautious on shares chiefly due to the disappointing track record when it came to delivering on margin expansion, cash flow improvements, and profitability targets. While significant work remains, we are encouraged by the recent restructuring initiatives, which include hiring a new CFO and naming new operating group presidents. In addition, mgmt has shown a new willingness to reduce certain investments and prune unprofitable businesses, highlighting a renewed focus on not just growing, but growing profitably."

Bruker Corporation closed at $18.09 on Wednesday.

Latest Ratings for BRKR

DateFirmActionFromTo
Jan 2017Deutsche BankInitiates Coverage OnHold
Jan 2017BarclaysDowngradesOverweightEqual-Weight
Dec 2016JP MorganDowngradesNeutralUnderweight

View More Analyst Ratings for BRKR
View the Latest Analyst Ratings

Posted-In: Bank of AmericaAnalyst Color Upgrades Analyst Ratings

 

Related Articles (BRKR)

View Comments and Join the Discussion!